But what about other companies?
A recent Moody’s investor report on the industry’s outlook estimates the net impact of the tax on 19 large companies nationwide. The estimates are based on a 35 percent corporate tax rate, or on a company’s own disclosures regarding the net effect of the device tax.
Here are the top 10 in descending order of magnitude, excluding Medtronic, which will rank No. 1 in terms of the amount it will fork over to the government:
Stryker Corporation — $77 million
Boston Scientific Corporation — $63 million
Covidien Plc — $61 million
St. Jude Medical Inc. — $40 million
Beckson, Dickinson and Company — $40 million
Zimmer Holdings — $34 million
C.R. Bard Inc. — $29 million
Biomet Inc. — $25 million
Kinetic Concepts Inc. — $24 million
Baxter International — $23 million
Reserve your seat now for MedCity CONVERGE, to be held July 9-10 in Philadelphia. Discover strategies, solutions and startups in healthcare innovation. Be a part of this gathering where the entire healthcare ecosystem converges.